During the last session, Biolife Solutions Inc (NASDAQ:BLFS)’s traded shares were 0.59 million, with the beta value of the company hitting 1.89. At the end of the trading day, the stock’s price was $26.01, reflecting an intraday gain of 2.44% or $0.62. The 52-week high for the BLFS share is $28.88, that puts it down -11.03 from that peak though still a striking 54.21% gain since the share price plummeted to a 52-week low of $11.91. The company’s market capitalization is $1.21B, and the average intraday trading volume over the past 10 days was 0.82 million shares, and the average trade volume was 368.93K shares over the past three months.
Biolife Solutions Inc (BLFS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BLFS has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.03.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biolife Solutions Inc (NASDAQ:BLFS) trade information
Biolife Solutions Inc (BLFS) registered a 2.44% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.44% in intraday trading to $26.01, hitting a weekly high. The stock’s 5-day price performance is 23.74%, and it has moved by 20.36% in 30 days. Based on these gigs, the overall price performance for the year is 91.67%. The short interest in Biolife Solutions Inc (NASDAQ:BLFS) is 3.5 million shares and it means that shorts have 13.43 day(s) to cover.
The consensus price target of analysts on Wall Street is $30, which implies an increase of 13.3% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $22 and $30 respectively. As a result, BLFS is trading at a discount of -15.34% off the target high and 15.42% off the low.
Biolife Solutions Inc (BLFS) estimates and forecasts
Statistics show that Biolife Solutions Inc has outperformed its competitors in share price, compared to the industry in which it operates. Biolife Solutions Inc (BLFS) shares have gone up 19.75% during the last six months, with a year-to-date growth rate more than the industry average at 80.92% against 11.50. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 84.47% this quarter and then jump 82.33% in the quarter after that. In the rating firms’ projections, revenue will decrease -22.23% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 22.77M as predicted by 10 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 22.63M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 32.73M and 31.73M respectively. In this case, analysts expect current quarter sales to shrink by -30.43% and then drop by -28.68% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 0.51%. While earnings are projected to return 65.30% in 2024, the next five years will return 10.00% per annum.
BLFS Dividends
Biolife Solutions Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Biolife Solutions Inc (NASDAQ:BLFS)’s Major holders
Biolife Solutions Inc insiders own 1.93% of total outstanding shares while institutional holders control 99.48%, with the float percentage being 101.44%. CASDIN CAPITAL, LLC is the largest shareholder of the company, while 277.0 institutions own stock in it. As of 2024-06-30, the company held over 8.71 million shares (or 19.1651% of all shares), a total value of $186.59 million in shares.
The next largest institutional holding, with 5.49 million shares, is of BLACKROCK INC.’s that is approximately 12.0797% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $117.61 million.
Also, the Mutual Funds coming in first place with the largest holdings of Biolife Solutions Inc (BLFS) shares are iShares Core S&P Smallcap ETF and Alger Small Cap Focus Fund . Data provided on Sep 30, 2024 indicates that iShares Core S&P Smallcap ETF owns about 2.29 shares. This amounts to just over 4.93 percent of the company’s overall shares, with a $59.46 million market value. The same data shows that the other fund manager holds slightly less at 1.41, or about 3.05% of the stock, which is worth about $36.8 million.
